Occludin protein family: Oxidative stress and reducing conditions

Antioxidants and Redox Signaling

Volumn 15, Issue 5, 2011, Pages 1195-1219

  Blasig, Ingolf E ^a   Bellmann, Christian ^a   Cording, Jimmi ^a   Vecchio, Giovanna Del ^a   Zwanziger, Denise ^a   Huber, Otmar ^b   Haseloff, Reiner F ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CYTOKINE; ISOPROTEIN; MEMBRANE PROTEIN; OCCLUDIN; PROTEIN MARVELD3; REACTIVE OXYGEN METABOLITE; TRICELLULIN; UNCLASSIFIED DRUG;

CHIMERA; HUMAN; HYPOXIA; INFECTION; INFLAMMATION; NONHUMAN; OLIGOMERIZATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

ANIMALS; HUMANS; MEMBRANE PROTEINS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS;

VERTEBRATA;

EID: 79960756844     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3542     Document Type: Review

References (226)

1. Ahdieh M, Vandenbos T, and Youakim A. Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma. Am J Physiol Cell Physiol 281: C2029-C2038, 2001.
2. Alam K, Ghousunnissa S, Nair S, Valluri VL, and Mukhopadhyay S. Glutathione-redox balance regulates c-rel-driven IL-12 production in macrophages: possible implications in antituberculosis immunotherapy. J Immunol 184: 2918-2929, 2010.
3. Alexandre J, Batteux F, Nicco C, Chereau C, Laurent A, Guillevin L, Weill B, and Goldwasser F. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 119: 41-48, 2006.
4. Amasheh M, Grotjohann I, Amasheh S, Fromm A, Soderholm JD, Zeitz M, Fromm M, and Schulzke JD. Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand J Gastroenterol 44: 1226-1235, 2009.
5. Andreeva AY, Krause E, Muller EC, Blasig IE, and Utepbergenov DI. Protein kinase C regulates the phosphorylation and cellular localization of occludin. J Biol Chem 276: 38480-38486, 2001.
6. Andreeva AY, Piontek J, Blasig IE, and Utepbergenov DI. Assembly of tight junction is regulated by the antagonism of conventional and novel protein kinase C isoforms. Int J Biol Chem Cell Biol 38: 222-233, 2006. (Pubitemid 41619451)
7. Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, and Gardner TW. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1: a potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 274: 23463-23467, 1999.
8. Arreola-Mendoza L, Del Razo LM, Mendoza-Garrido ME, Martin D, Namorado MC, Calderon-Salinas JV, and Reyes JL. The protective effect of alpha-tocopherol against dichromate-induced renal tight junction damage is mediated via ERK1/2. Toxicol Lett 191: 279-288, 2009.
9. Arreola-Mendoza L, Reyes JL, Melendez E, Martin D, Namorado MC, Sanchez E, and Del Razo LM. Alphatocopherol protects against the renal damage caused by potassium dichromate. Toxicology 218: 237-246, 2006. (Pubitemid 41821354)
10. Bailey TA, Kanuga N, Romero IA, Greenwood J, Luthert PJ, and Cheetham ME. Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 45: 675-684, 2004. (Pubitemid 38140530)
11. Balda MS, Anderson JM, and Matter K. The SH3 domain of the tight junction protein ZO-1 binds to a serine protein kinase that phosphorylates a region C-terminal to this domain. FEBS Lett 399: 326-332, 1996. (Pubitemid 26426876)
12. Balda MS, Whitney JA, Flores C, Gonzalez S, Cereijido M, and Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 134: 1031-1049, 1996. (Pubitemid 26278226)
13. Bamforth SD,Kniesel U,WolburgH, Engelhardt B, and Risau W. A dominant mutant of occludin disrupts tight junction structure and function. J Cell Sci 112: 1879-1888, 1999. (Pubitemid 29338813)
14. Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, Donovan RS, Shinjo F, Liu YM, Dembowy J, Taylor IW, Luga V, Przulj N, Robinson M, Suzuki H, Hayashizaki Y, Jurisica I, and Wrana JL. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307: 1621-1625, 2005. (Pubitemid 40354744)
15. Basuroy S, Seth A, Elias B, Naren AP, and Rao R. MAR interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochem J 393: 69-77, 2006. (Pubitemid 43049303)
16. Bates DO. Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 87: 262-271, 2010.
17. Bauer AT, Burgers HF, Rabie T, and Marti HH. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cerebr Blood Flow Metab 30: 837-848, 2010.
18. Bazzoni G. Pathobiology of junctional adhesion molecules. Antioxid Redox Signal 15: 1221-1234, 2011.
19. Bazzoni G, Martinez-Estrada OM, Orsenigo F, Cordenonsi M, Citi S, and Dejana E. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J Biol Chem 275: 20520-20526, 2000. (Pubitemid 30457633)
20. Beauchesne E, Desjardins P, Hazell AS, and Butterworth RF. eNOS gene deletion restores blood-brain barrier integrity and attenuates neurodegeneration in the thiaminedeficient mouse brain. J Neurochem 111: 452-459, 2009.
21. Billings SD, Walsh SV, Fisher C, Nusrat A, Weiss SW, and Folpe AL. Aberrant expression of tight junction-related proteins ZO-1, claudin-1 and occludin in synovial sarcoma: an immunohistochemical study with ultrastructural correlation. Mod Pathol 17: 141-149, 2004. (Pubitemid 41656509)
22. Birukov KG, Leitinger N, Bochkov VN, and Garcia JGN. Signal transduction pathways activated in human pulmonary endothelial cells by OxPAPC, a bioactive component of oxidized lipoproteins. Microvasc Res 67: 18-28, 2004. (Pubitemid 38050220)
23. Blasig IE, Mertsch K, and Haseloff RF. Nitronyl nitroxides, a novel group of protective agents against oxidative stress in endothelial cells forming the blood-brain barrier. Neuropharmacology 43: 1006-1014, 2002. (Pubitemid 35341236)
24. Blasig IE, Winkler L, Lassowski B, Mueller SL, Zuleger N, Krause E, Krause G, Gast K, Kolbe M, and Piontek J. On the self-association potential of transmembrane tight junction proteins. Cell Mol Life Sci 63: 505-514, 2006.
25. Bruban J, Glotin AL, Dinet V, Chalour N, Sennlaub F, Jonet L, An N, Faussat AM, and Mascarelli F. Amyloid-beta(1-42) alters structure and function of retinal pigmented epithelial cells. Aging Cell 8: 162-177, 2009.
26. Bruewer M, Utech M, Ivanov AI, Hopkins AM, Parkos CA, and Nusrat A. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosislike process. FASEB J 19: 923-933, 2005. (Pubitemid 40827713)
27. Buday A, Orsy P, Godo M, Mozes M, Kokeny G, Lacza Z, Koller A, Ungvari Z, Gross ML, Benyo Z, and Hamar P. Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice. Am J Physiol Heart Circ Physiol 299: H386-H395, 2010.
28. Burgel N, Bojarski C, Mankertz J, Zeitz M, Fromm M, and Schulzke JD. Mechanisms of diarrhea in collagenous colitis. Gastroenterology 123: 433-443, 2002. (Pubitemid 34827187)
29. Busch C, Hanssen TA, Wagener C, and Obrink B. Downregulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum Pathol 33: 290-298, 2002. (Pubitemid 34461462)
30. Carrano A, Hoozemans JJM, van der Vies SM, Rozemuller AJM, van Horssen J, and de Vries HE. Amyloid beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal 15: 1167-1178, 2011.
31. Castello G, Scala S, Palmieri G, Curley SA, and Izzo F. HCV-related hepatocellular carcinoma: from chronic inflammation to cancer. Clin Immunol 134: 237-250, 2010.
32. Chen SHM, Stins MF, Huang SH, Chen YH, Kwon-Chung KJ, Chang Y, Kim KS, Suzuki K, and Jong AY. Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol 52: 961-970, 2003. (Pubitemid 38648135)
33. Chen YH, Lu Q, Goodenough DA, and Jeansonne B. Nonreceptor tyrosine kinase c-Yes interacts with occludin during tight junction formation in canine kidney epithelial cells. Mol Biol Cell 13: 1227-1237, 2002. (Pubitemid 34309618)
34. Chishti MS, Bhatti A, Tamim S, Lee K, McDonald ML, Leal SM, and Ahmad W. Splice-site mutations in the TRIC gene underlie autosomal recessive nonsyndromic hearing impairment in Pakistani families. J Hum Genet 53: 101-105, 2008.
35. Choi WS, Eum SY, Lee YW, Hennig B, Robertson LW, and Toborek M. PCB 104-induced proinflammatory reactions in human vascular endothelial cells: relationship to cancer metastasis and atherogenesis. Toxicol Sci 75: 47-56, 2003. (Pubitemid 37098735)
36. Chung NPY and Cheng CY. Is cadmium chloride-induced inter-Sertoli tight junction permeability barrier disruption a suitable in vitro model to study the events of junction disassembly during spermatogenesis in the rat testis? Endocrinology 142: 1878-1888, 2001. (Pubitemid 32405945)
37. Clayburgh DR, Barrett TA, Tang YM, Meddings JB, Van Eldik LJ, Watterson DM, Clarke LL, Mrsny RJ, and Turner JR. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest 115: 2702-2715, 2005. (Pubitemid 41434398)
38. Cobb MH, Hepler JE, Cheng MG, and Robbins D. The mitogen-activated protein-kinases, Erk1 and Erk2. Semin Cancer Biol 5: 261-268, 1994.
39. Coeffier M, Gloro R, Boukhettala N, Aziz M, Lecleire S, Vandaele N, Antonietti M, Savoye G, Bole-Feysot C, Dechelotte P, Reimund JM, and Ducrotte P. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Am J Gastroenterol 105: 1181-1188, 2010.
40. Cohen TS, Lawrence GG, Khasgiwala A, and Margulies SS. MAPk activation modulates permeability of isolated rat alveolar epithelial cell monolayers following cyclic stretch. PLoS One 5: 23-42, 2010.
41. Coisne C and Engelhardt B. Tight junctions in brain barriers during CNS inflammation. Antioxid Redox Signal 15: 1285-1303, 2011.
42. Collins NT, Cummins PM, Colgan OC, Ferguson G, Birney YA, Murphy RP, Meade G, and Cahill PA. Cyclic strainmediated regulation of vascular endothelial occludin and ZO-1: influence on intercellular tight junction assembly and function. Arterioscler Thromb Vasc Biol 26: 62-68, 2006. (Pubitemid 43732229)
43. Cordenonsi M, Mazzon E, De Rigo L, Baraldo S, Meggio F, and Citi S. Occludin dephosphorylation in early development of Xenopus laevis. J Cell Sci 110: 3131-3139, 1997. (Pubitemid 28026444)
44. Cordenonsi M, Turco F, D'Atri F, Hammar E, Martinucci G, Meggio F, and Citi S. Xenopus laevis occludin: identification of in vitro phosphorylation sites by protein kinase CK2 and association with cingulin. Eur J Biochem 264: 374-384, 1999. (Pubitemid 29424441)
45. Cumming RC, Andon NL, Haynes PA, Park M, Fischer WH, and Schubert D. Protein disulfide bond formation in the cytoplasm during oxidative stress. J Biol Chem 279: 21749-21758, 2004. (Pubitemid 38679361)
46. Cuzzocrea S, Mazzon E, De Sarro A, and Caputi AP. Role of free radicals and poly(ADP-ribose) synthetase in intestinal tight junction permeability. Mol Med 6: 766-778, 2000.
47. Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, and Achim CL. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 155: 1915-1927, 1999.
48. DeMaio L, Rouhanizadeh M, Reddy S, Sevanian A, Hwang J, and Hsiai TK. Oxidized phospholipids mediate occludin expression and phosphorylation in vascular endothelial cells. Am J Physiol Heart Circ Physiol 290: H674-H683, 2006.
49. Dickman KG, Hempson SJ, Anderson J, Lippe S, Zhao LM, Burakoff R, and Shaw RD. Rotavirus alters paracellular permeability and energy metabolism in Caco-2 cells. Am J Physiol Gastrointest 279: G757-G766, 2000.
50. Dimitrijevic OB, Stamatovic SM, Keep RF, and Andjelkovic AV. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J Cerebr Blood Flow Metab 26: 797-810, 2006.
51. Dorfel MJ, Westphal JK, and Huber O. Differential phosphorylation of occludin and tricellulin by CK2 and CK1. Ann N Y Acad Sci 1165: 69-73, 2009.
52. Elias BC, Suzuki T, Seth A, Giorgianni F, Kale G, Shen L, Turner JR, Naren A, Desiderio DM, and Rao R. Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions. J Biol Chem 284: 1559-1569, 2009.
53. Everett RS, Vanhook MK, Barozzi N, Toth I, and Johnson LG. Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Mol Pharmacol 69: 492-500, 2006. (Pubitemid 43121946)
54. Fanning AS, Jameson BJ, Jesaitis LA, and Anderson JM. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 273: 29745-29753, 1998. (Pubitemid 28509986)
55. Ferruzza S, Scacchi M, Scarino ML, and Sambuy Y. Iron and copper alter tight junction permeability in human intestinal Caco-2 cells by distinct mechanisms. Toxicol In Vitro 16: 399-404, 2002. (Pubitemid 34759983)
56. Forster C, Kahles T, Kietz S, and Drenckhahn D. Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND. J Physiol 580: 937-949, 2007. (Pubitemid 46915250)
57. Fries W, Mazzon E, Squarzoni S, Martin A, Martines D, Micali A, Sturniolo GC, Citi S, and Longo G. Experimental colitis increases small intestine permeability in the rat. Lab Invest 79: 49-57, 1999. (Pubitemid 29063762)
58. Fujimoto K. Freeze-fracture replica electron-microscopy combined with Sds digestion for cytochemical labeling of integral membrane-proteins: application to the immunogold labeling of intercellular junctional complexes. J Cell Sci 108: 3443-3449, 1995.
59. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, and Tsukita S. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 476: 258-261, 2000. (Pubitemid 30410828)
60. Fujita M, Tsuruta R, Kaneko T, Otsuka Y, Kutsuna S, Izumi T, Aoki T, Shitara M, Kasaoka S, Maruyama I, Yuasa M, and Maekawa T. Hyperoxia suppresses excessive superoxide anion radical generation in blood, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia/reperfusion rats: laboratory study. Shock 34: 299-305, 2010.
61. Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, Tsukita S, and Tsukita S. Direct association of occludin with Zo-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol 127: 1617-1626, 1994. (Pubitemid 24380900)
62. Furuse M, Sasaki H, Fujimoto K, and Tsukita S. A single gene product, claudin-1 or-2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 143: 391-401, 1998. (Pubitemid 28487858)
63. Gasser M, Riediker M, Mueller L, Perrenoud A, Blank F, Gehr P, and Rothen-Rutishauser B. Toxic effects of brake wear particles on epithelial lung cells in vitro. Part Fibre Toxicol 6: 241-267, 2009.
64. Gassler N, Rohr C, Schneider A, Kartenbeck J, Bach A, Overmuller N, Otto HF, and Autschbach F. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest 281: G216-G228, 2001.
65. Gatenby RA and Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899, 2004. (Pubitemid 39472955)
66. Gatti CD, Osto E, Kouroedov A, Eto M, Shaw S, Volpe M, Luscher TF, and Cosentino F. Pulsatile stretch induces release of angiotensin II and oxidative stress in human endothelial cells: effects of ACE inhibition and AT(1) receptor antagonism. Clin Exp Hypertens 30: 616-627, 2008.
67. Gershwin LJ. Effects of allergenic extracts on airway epithelium. Curr Allergy Asthma Rep 7: 357-362, 2007. (Pubitemid 47377324)
68. Ghassemifar MR, Sheth B, Papenbrock T, Leese HJ, Houghton FD, and Fleming TP. Occludin TM4(-): an isoform of the tight junction protein present in primates lacking the fourth transmembrane domain. J Cell Sci 115: 3171-3180, 2002.
69. Giandomenico AR, Cerniglia GE, Biaglow JE, Stevens CW, and Koch CJ. The importance of sodium pyruvate in assessing damage produced by hydrogen peroxide. Free Radic Biol Med 23: 426-434, 1997. (Pubitemid 27276779)
70. Gonzalez JE, DiGeronimo RJ, Arthur DE, and King JM. Remodeling of the tight junction during recovery from exposure to hydrogen peroxide in kidney epithelial cells. Free Radic Biol Med 47: 1561-1569, 2009.
71. González-Mariscal L
72. Guo SH, Wharton W, Moseley P, and Shi HL. Heat shock protein 70 regulates cellular redox status by modulating glutathione-related enzyme activities. Cell Stress Chaperones 12: 245-254, 2007. (Pubitemid 351199387)
73. Hackett TL, Warner SM, Stefanowicz D, Shaheen F, Pechkovsky DV, Murray LA, Argentieri R, Kicic A, Stick SM, Bai TR, and Knight DA. Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta 1. Am J Respir Crit Care Med 180: 122-133, 2009.
74. Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J 401: 1-11, 2007. (Pubitemid 46115897)
75. Han G, Ye M, Liu H, Song C, Sun D, Wu Y, Jiang X, Chen R, Wang C, Wang L, and Zou H. Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis. Electrophoresis 31: 1080-1089, 2010.
76. Han M, Pendem S, Teh SL, Sukumaran DK, Wu F, and Wilson JX. Ascorbate protects endothelial barrier function during septic insult: role of protein phosphatase type 2A. Free Radic Biol Med 48: 128-135, 2010.
77. Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, and Antonetti DA. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci 47: 5106-5115, 2006. (Pubitemid 46586418)
78. Harris HJ, Davis C, Mullins JGL, Hu K, Goodall M, Farquhar MJ, Mee CJ, McCaffrey K, Young S, Drummer H, Balfe P, and McKeating JA. Claudin association with CD81 defines hepatitis C virus entry. J Biol Chem 285: 21092-21102, 2010.
79. Hashimoto K, Oshima T, Tomita T, Kim Y, Matsumoto T, Joh T, and Miwa H. Oxidative stress induces gastric epithelial permeability through claudin-3. Biochem Biophys Res Commun 376: 154-157, 2008.
80. Haskins J, Gu LJ, Wittchen ES, Hibbard J, and Stevenson BR. ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J Cell Biol 141: 199-208, 1998. (Pubitemid 28182652)
81. Ho TC, Yang YC, Cheng HC, Wu AC, Chen SL, and Tsao YP. Pigment epithelium-derived factor protects retinal pigment epithelium from oxidant-mediated barrier dysfunction. Biochem Biophys Res Commun 342: 372-378, 2006.
82. Huber D, Balda MS, and Matter K. Occludin modulates transepithelial migration of neutrophils. J Biol Chem 275: 5773-5778, 2000. (Pubitemid 30115221)
83. Hull BE and Staehelin LA. Functional significance of variations in geometrical organization of tight junction networks. J Cell Biol 68: 688-704, 1976.
84. Hwang C, Sinskey AJ, and Lodish HF. Oxidized redox state of glutathione in the endoplasmic-reticulum. Science 257: 1496-1502, 1992.
85. Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, and Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 171: 939-945, 2005. (Pubitemid 41815826)
86. Ikenouchi J, Sasaki H, Tsukita S, Furuse M, and Tsukita S. Loss of occludin affects tricellular localization of tricellulin. Mol Biol Cell 19: 4687-4693, 2008.
87. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, and Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2 and ZO-3, with the COOH termini of claudins. J Cell Biol 147: 1351-1363, 1999. (Pubitemid 30012818)
88. Ivanov AI, Nusrat A, and Parkos CA. Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment. Mol Biol Cell 15: 176-188, 2004. (Pubitemid 38044954)
89. Jamaluddin MS, Lin PH, Yao QZ, and Chen CY. Non-nucleoside reverse transcriptase inhibitor efavirenz increases monolayer permeability of human coronary artery endothelial cells. Atherosclerosis 208: 104-111, 2010.
90. Jamaluddin MS, Wang XW, Wang H, Rafael C, Yao QZ, and Chen CY. Eotaxin increases monolayer permeability of human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 29: 2146-2346, 2009.
91. Jiang WG, Bryce RP, Horrobin DF, and Mansel RE. Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids. Biochem Biophys Res Commun 244: 414-420, 1998. (Pubitemid 28414097)
92. Jiang WG, Martin TA, Matsumoto K, Nakamura T, and Mansel RE. Hepatocyte growth factor/scatter factor de-creases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells. J Cell Physiol 181: 319-329, 1999. (Pubitemid 29463647)
93. John LJ, Fromm M, and Schulzke JD. Epithelial barriers in intestinal inflammation. Antioxid Redox Signal 15: 1255-1270, 2011.
94. Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y, and Fields JZ. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52: 720-728, 2003. (Pubitemid 36528876)
95. Kevil CG, Oshima T, Alexander B, Coe LL, and Alexander JS. H2O2-mediated permeability: role of MAPK and occludin. Am J Physiol-Cell Physiol 279: C21-C30, 2000. (Pubitemid 30616618)
96. Khan M, Im YB, Shunmugavel A, Gilg AG, Dhindsa RK, Singh AK, and Singh I. Administration of Snitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. J Neuroinflammation 6: 67-71, 2009.
97. Khandelwal P, Abraham SN, and Apodaca G. Cell biology and physiology of the uroepithelium. Am J Physiol Renal 297: F1477-F1501, 2009.
98. Kim YA, Park SL, Kim MY, Lee SH, Baik EJ, Moon CH, and Jung YS. Role of PKC beta II and PKC delta in blood-brain barrier permeability during aglycemic hypoxia. Neurosci Lett 468: 254-258, 2010.
99. Kimura K, Teranishi S, Kawamoto K, and Nishida T. Protection of human corneal epithelial cells from hypoxia-induced disruption of barrier function by hepatocyte growth factor. Exp Eye Res 90: 337-343, 2010.
100. Koedel U, Winkler F, Angele B, Fontana T, and Pfister HW. Meningitis-associated central nervous system complications are mediated by the activation of poly(ADPribose) polymerase. J Cerebr Blood Flow Metab 22: 39-49, 2002. (Pubitemid 34038381)
101. Kojima T, Sawada N, Chiba H, Kokai Y, Yamamoto M, Urban M, Lee GH, Hertzberg EL, Mochizuki Y, and Spray DC. Induction of tight junctions in human connexin 32 (hCx32)-transfected mouse hepatocytes: connexin 32 interacts with occludin. Biochem Biophys Res Commun 266: 222-229, 1999. (Pubitemid 30028795)
102. Kojima T, Takano K, Yamamoto T, Murata M, Son S, Imamura M, Yamaguchi H, Osanai M, Chiba H, Himi T, and Sawada N. Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes. Liver Int 28: 534-545, 2008. (Pubitemid 351411141)
103. Kondoh M, Masuyama A, Takahashi A, Asano N, Mizuguchi H, Koizumi N, Fujii M, Hayakawa T, Horiguchi Y, and Watanbe Y. A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol Pharmacol 67: 749-756, 2005. (Pubitemid 40365322)
104. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, and Blasig IE. Structure and function of claudins. BBA-Rev Biomembranes 1778: 631-645, 2008.
105. Krizbai IA, Bauer H, Bresgen N, Eckl PM, Farkas A, Szatmari E, Traweger A, Wejksza K, and Bauer HC. Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells. Cell Mol Neurobiol 25: 129-139, 2005. (Pubitemid 40558586)
106. Krizbai IA, Lenzser G, Szatmari E, Farkas AE, Wilhelm I, Fekete Z, Erdos B, Bauer H, Bauer HC, Sandor P, and Komjati K. Blood-brain barrier changes during compensated and decompensated hemorrhagic shock. Shock 24: 428-433, 2005. (Pubitemid 41567354)
107. Krug SM, Amasheh S, Richter JF, Milatz S, Gunzel D, Westphal JK, Huber O, Schulzke JD, and Fromm M. Tricellulin forms a barrier to macromolecules in tricellular tight junctions without affecting ion permeability. Mol Biol Cell 20: 3713-3724, 2009.
108. Kucharzik T, Walsh SV, Chen J, Parkos CA, and Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 159: 2001-2009, 2001. (Pubitemid 33104255)
109. Kuwabara H, Kokai Y, Kojima T, Takakuwa R, Mori M, and Sawada N. Occludin regulates actin cytoskeleton in endothelial cells. Cell Struct Funct 26: 109-116, 2001. (Pubitemid 32747235)
110. Lacaz-Vieira F, Jaeger MMM, Farshori P, and Kachar B. Small synthetic peptides homologous to segments of the first external loop of occludin impair tight junction resealing. J Membr Biol 168: 289-297, 1999. (Pubitemid 29177866)
111. Lapierre LA, Tuma PL, Navarre J, Goldenring JR, and Anderson JM. VAP-33 localizes to both an intracellular vesicle population and with occludin at the tight junction. J Cell Sci 112: 3723-3732, 1999.
112. Lassiter C, Fan X, Joshi PC, Jacob BA, Sutliff RL, Jones DP, Koval M, and Guidot DM. HIV-1 transgene expression in rats causes oxidant stress and alveolar epithelial barrier dysfunction. AIDS Res Ther 6: 1, 2009.
113. Li QR, Zhang Q, Wang CY, Liu XX, Qu LL, Gu LL, Li N, and Li JS. Altered distribution of tight junction proteins after intestinal ischaemia/reperfusion injury in rats. J Cell Mol Med 13: 4061-4076, 2009.
114. Li YH, Fanning AS, Anderson JM, and Lavie A. Structure of the conserved cytoplasmic C-terminal domain of occludin: identification of the ZO-1 binding surface. J Mol Biol 352: 151-164, 2005. (Pubitemid 41213309)
115. Lin JL, Huang YH, Shen YC, Huang HC, and Liu PH. Ascorbic acid prevents blood-brain barrier disruption and sensory deficit caused by sustained compression of primary somatosensory cortex. J Cereb Blood Flow Metab 30: 1121-1136, 2010.
116. Lischper M, Beuck S, Thanabalasundaram G, Pieper C, and Galla HJ. Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions. Brain Res 1326: 114-127, 2010.
117. Liu WL, Sood R, Chen QC, Sakoglu U, Hendren J, Cetin O, Miyake M, and Liu KJ. Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke. J Neurochem 107: 1196-1205, 2008.
118. Lochhead JJ, McCaffrey G, Quigley CE, Finch J, DeMarco KM, Nametz N, and Davis TP. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab 30: 1625-1636, 2010.
119. Maeda S, Nakagawa S, Suga M, Yamashita E, Oshima A, Fujiyoshi Y, and Tsukihara T. Structure of the connexin 26 gap junction channel at 3.5 angstrom resolution. Nature 458: 597-601, 2009.
120. Maier CM, Hsieh L, Crandall T, Narasinnhan P, and Chan PH. A new approach for the investigation of reperfusionrelated brain injury. Biochem Soc Trans 34: 1366-1369, 2006. (Pubitemid 46769056)
121. Mankertz J, Waller JS, Hillenbrand B, Tavalali S, Florian P, Schoneberg T, Fromm M, and Schulzke JD. Gene expression of the tight junction protein occludin includes differential splicing and alternative promoter usage. Biochem Biophys Res Commun 298: 657-666, 2002. (Pubitemid 35356791)
122. Marco S and Skaper SD. Amyloid beta-peptide(1-42) alters tight junction protein distribution and expression in brain microvessel endothelial cells. Neurosci Lett 401: 219-224, 2006. (Pubitemid 44250979)
123. Martin TA, Das T, Mansel RE, and Jiang WG. Synergistic regulation of endothelial tight junctions by antioxidant (Se) and polyunsaturated lipid (GLA) via claudin-5 modulation. J Cell Biochem 98: 1308-1319, 2006. (Pubitemid 44128368)
124. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER III, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, and Elledge SJ. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316: 1160-1166, 2007. (Pubitemid 46877472)
125. Matter K and Balda MS. Biogenesis of tight junctions: the C-terminal domain of occludin mediates basolateral targeting. J Cell Sci 111: 511-519, 1998. (Pubitemid 28098399)
126. McCaffrey G, Seelbach MJ, Staatz WD, Nametz N, Quigley C, Campos CR, Brooks TA, and Davis TP. Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. J Neurochem 106: 2395-2409, 2008.
127. McCaffrey G, Staatz WD, Quigley CA, Nametz N, Seelbach MJ, Campos CR, Brooks TA, Egleton RD, and Davis TP. Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J Neurochem 103: 2540-2555, 2007.
128. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, Lynch RD, and Schneeberger EE. Occludin is a functional component of the tight junction. J Cell Sci 109: 2287-2298, 1996. (Pubitemid 26325491)
129. McDermott JR, Bartram RE, Knight PA, Miller HRP, Garrod DR, and Grencis RK. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci USA 100: 7761-7766, 2003. (Pubitemid 36760043)
130. McKenzie JAG, Riento K, and Ridley AJ. Casein kinase I epsilon associates with and phosphorylates the tight junction protein occludin. FEBS Lett 580: 2388-2394, 2006.
131. McNamara BP, Koutsouris A, O'Connell CB, Nougayrede JP, Donnenberg MS, and Hecht G. Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function. J Clin Invest 107: 621-629, 2001. (Pubitemid 32205183)
132. Medici D, Hay ED, and Goodenough DA. Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta 1-induced epithelial-mesenchymal transition. Mol Biol Cell 17: 1871-1879, 2006. (Pubitemid 44011602)
133. Meyer TN, Schwesinger C, Ye JM, Denker BM, and Nigam SK. Reassembly of the tight junction after oxidative stress depends on tyrosine kinase activity. J Biol Chem 276: 44354-44355, 2001.
134. Minagar A, Ostanin D, Long AC, Jennings M, Kelley RE, Sasaki M, and Alexander JS. Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells. Mult Scler 9: 235-238, 2003. (Pubitemid 36681887)
135. Mitic LL, Schneeberger EE, Fanning AS, and Anderson JM. Connexin-occludin chimeras containing the ZO-binding domain of occludin localize at MDCK tight junctions and NRK cell contacts. J Cell Biol 146: 683-693, 1999. (Pubitemid 29388141)
136. Miura Y and Roider J. Triamcinolone acetonide prevents oxidative stress-induced tight junction disruption of retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol 247: 641-649, 2009.
137. Morimoto S, Nishimura N, Terai T, Manabe S, Yamamoto Y, Shinahara W, Miyake H, Tashiro S, Shimada M, and Sasaki T. Rab13 mediates the continuous endocytic recycling of occludin to the cell surface. J Biol Chem 280: 2220-2228, 2005.
138. Muller SL, Portwich M, Schmidt A, Utepbergenov DI, Huber O, Blasig IE, and Krause G. The tight junction protein occludin and the adherens junction protein alphacatenin share a common interaction mechanism with ZO-1. J Biol Chem 280: 3747-3756, 2005. (Pubitemid 40223843)
139. Murakami T, Felinski EA, and Antonetti DA. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factorinduced permeability. J Biol Chem 284: 21036-21046, 2009.
140. Muresan Z, Paul DL, and Goodenough DA. Occludin 1B, a variant of the tight junction protein occludin. Mol Biol Cell 11: 627-634, 2000. (Pubitemid 30112170)
141. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, Arsenault AL, and Kaushic C. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 6: 23-27, 2010.
142. Nicaise C, Mitrecic D, Demetter P, De Decker R, Authelet M, Boom A, and Pochet R. Impaired blood-brain and blood-spinal cord barriers in mutant SOM-linked ALS rat. Brain Res 1301: 152-162, 2009.
143. Noseworthy MD and Bray TM. Zinc deficiency exacerbates loss in blood-brain barrier integrity induced by hyperoxia measured by dynamic MRI. Proc Soc Exp Biol Med 223: 175-182, 2000. (Pubitemid 30339440)
144. Nunbhakdi-Craig V, Craig L, Machleidt T, and Sontag E. Simian virus 40 small tumor antigen induces deregulation of the actin cytoskeleton and tight junctions in kidney epithelial cells. J Virol 77: 2807-2818, 2003. (Pubitemid 36228064)
145. Nusrat A, Chen JA, Foley CS, Liang TW, Tom J, Cromwell M, Quan C, and Mrsny RJ. The coiled-coil domain of occludin can act to organize structural and functional elements of the epithelial tight junction. J Biol Chem 275: 29816-29822, 2000. (Pubitemid 32043866)
146. Nusrat A, Parkos CA, Verkade P, Foley CS, Liang TW, Innis-Whitehouse W, Eastburn KK, and Madara JL. Tight junctions are membrane microdomains. J Cell Sci 113: 1771-1781, 2000. (Pubitemid 30333126)
147. Nusrat A, von Eichel-Streiber C, Turner JR, Verkade P, Madara JL, and Parkos CA. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect Immun 69: 1329-1336, 2001. (Pubitemid 32187577)
148. Olivera D, Knall C, Boggs S, and Seagrave J. Cytoskeletal modulation and tyrosine phosphorylation of tight junction proteins are associated with mainstream cigarette smokeinduced permeability of airway epithelium. Exp Toxicol Pathol 62: 133-143, 2010.
149. Overgaard CE, Daugherty BL, Mitchell LA, and Koval M. Claudins: control of barrier function and regulation in response to oxidant stress. Antioxid Redox Signal 15: 1179-1193, 2011.
150. Palumaa P. Biological redox switches. Antioxid Redox Signal 11: 981-983, 2009.
151. Panayiotidis M. Reactive oxygen species (ROS) in multistage carcinogenesis. Cancer Lett 266: 3-5, 2008.
152. Papadopoulos MC, Saadoun S, Woodrow CJ, Davies DC, Costa-Martins P, Moss RF, Krishna S, and Bell BA. Occludin expression in microvessels of neoplastic and nonneoplastic human brain. Neuropathol Appl Neurobiol 27: 384-395, 2001. (Pubitemid 32990079)
153. Park JH, Okayama N, Gute D, Krsmanovic A, Battarbee H, and Alexander JS. Hypoxia/aglycemia increases endothelial permeability: role of second messengers and cytoskeleton. Am J Physiol Cell Physiol 277: C1066-C1074, 1999. (Pubitemid 30045963)
154. Peng BH, Lee JC, and Campbell GA. In vitro protein complex formation with cytoskeleton-anchoring domain of occludin identified by limited proteolysis. J Biol Chem 278: 49644-49651, 2003.
155. Peng ZM, Geh E, Chen L, Meng QH, Fan YX, Sartor M, Shertzer HG, Liu ZG, Puga A, and Xia Y. Inhibitor of kappa B kinase beta regulates redox homeostasis by controlling the constitutive levels of glutathione. Mol Pharmacol 77: 784-792, 2010.
156. Piontek J, Winkler L, Wolburg H, Muller SL, Zuleger N, Piehl C, Wiesner B, Krause G, and Blasig IE. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J 22: 146-158, 2008.
157. Poritz LS, Garver KI, Tilberg AF, and Koltun WA. Tumor necrosis factor alpha disrupts tight junction assembly. J Surg Res 116: 14-18, 2004. (Pubitemid 38083280)
158. Proia P, Schiera G, Salemi G, Ragonese P, Savettieri G, and Di Liegro I. Neuronal and BBB damage induced by sera from patients with secondary progressive multiple sclerosis. Int J Mol Med 24: 743-747, 2009.
159. Raleigh DR, Marchiando AM, Zhang Y, Shen L, Sasaki H, Wang YM, Long MY, and Turner JR. Tight junction-associated MARVEL proteins marvelD3, tricellulin, and occludin have distinct but overlapping functions. Mol Biol Cell 21: 1200-1213, 2010.
160. Rao RK, Basuroy S, Rao VU, Karnaky KJ, and Gupta A. Tyrosine phosphorylation and dissociation of occludin-Z0-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J 368: 471-481, 2002. (Pubitemid 35454525)
161. Reed MC, Thomas RL, Pavisic J, James SJ, Ulrich CM, and Nijhout HF. A mathematical model of glutathione metabolism. Theoret Biol Med Model 5: 341-352, 2008.
162. Riazuddin S, Ahmed ZM, Fanning AS, Lagziel A, Kitajiri S, Ramzan K, Khan SN, Chattaraj P, Friedman PL, Anderson JM, Belyantseva IA, Forge A, Riazuddin S, and Friedman TB. Tricellulin is a tight-junction protein necessary for hearing. Am J Hum Genet 79: 1040-1051, 2006. (Pubitemid 44853475)
163. Roche HM, Terres AM, Black IB, Gibney MJ, and Kelleher D. Fatty acids and epithelial permeability: effect of conjugated linoleic acid in Caco-2 cells. Gut 48: 797-802, 2001. (Pubitemid 32476981)
164. Roig-Perez S, Cortadellas N, Moreto M, and Ferrer R. Intracellular mechanisms involved in docosahexaenoic acidinduced increases in tight junction permeability in Caco-2 cell monolayers. J Nutr 140: 1557-1563, 2010.
165. Rothen-Rutishauser B, Grass RN, Blank F, Limbach LK, Muehlfeld C, Brandenberger C, Raemy DO, Gehr P, and Stark WJ. Direct combination of nanoparticle fabrication and exposure to lung cell cultures in a closed setup as a method to simulate accidental nanoparticle exposure of humans. Environ Sci Technol 43: 2634-2640, 2009.
166. Saenz-Morales D, Conde E, Escribese MM, Garcia-Martos M, Alegre L, Blanco-Sanchez I, and Garcia-Bermejo ML. ERK1/2 mediates cytoskeleton and focal adhesion impairment in proximal epithelial cells after renal ischemia. Cell Physiol Biochem 23: 285-294, 2009.
167. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, and Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11: 4131-4142, 2000.
168. Sakakibara A, Furuse M, Saitou M, AndoAkatsuka Y, and Tsukita S. Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 137: 1393-1401, 1997. (Pubitemid 27265950)
169. Sanchez-Pulido L, Martin-Belmonte F, Valencia A, and Alonso MA. MARVEL: a conserved domain involved in membrane apposition events. Trends Biochem Sci 27: 599-601, 2002. (Pubitemid 35435304)
170. Scharl M, Paul G, Barrett KE, and Mccole DF. AMPactivated protein kinase mediates the interferon-gammainduced decrease in intestinal epithelial barrier function. J Biol Chem 284: 27952-27963, 2009.
171. Schluter H, Moll I, Wolburg H, and Franke WW. The different structures containing tight junction proteins in epidermal and other stratified epithelial cells, including squamous cell metaplasia. Eur J Cell Biol 86: 645-655, 2007. (Pubitemid 350082195)
172. Schmitt M, Klonowski-Stumpe H, Eckert M, Luthen R, and Haussinger D. Disruption of paracellular sealing is an early event in acute caerulein-pancreatitis. Pancreas 28: 181-190, 2004. (Pubitemid 38269779)
173. Schrammel A, Gorren ACF, Schmidt K, Pfeiffer S, and Mayer B. S-nitrosation of glutathione by nitric oxide, peroxynitrite, and (NO)-N$-/O-2$-). Free Radic Biol Med 34: 1078-1088, 2003. (Pubitemid 36398568)
174. Schreibelt G, Kooij G, Reijerkerk A, van Doorn R, Gringhuis SI, van der Pol S, Weksler BB, Romero IA, Couraud PO, Piontek J, Blasig IE, Dijkstra CD, Ronken E, and de Vries HE. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 21: 3666-3676, 2007. (Pubitemid 350075154)
175. Schwarz BT, Wang FJ, Shen L, Clayburgh DR, Su LP, Wang YM, Fu YX, and Turner JR. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology 132: 2383-2394, 2007. (Pubitemid 46900820)
176. Seelbach M, Chen L, Powell A, Choi YJ, Zhang B, Hennig B, and Toborek M. Polychlorinated biphenyls disrupt bloodbrain barrier integrity and promote brain metastasis formation. Environ Health Perspect 118: 479-484, 2010.
177. Seth A, Sheth P, Elias BC, and Rao R. Protein phosphatases 2A and 1 interact with occludin and negatively regulate the assembly of tight junctions in the CACO-2 cell monolayer. J Biol Chem 282: 11487-11498, 2007. (Pubitemid 47100808)
178. Shen L and Turner JR. Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Mol Biol Cell 16: 3919-3936, 2005. (Pubitemid 41262867)
179. Shen L, Weber CR, and Turner JR. The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state. J Cell Biol 181: 683-695, 2008. (Pubitemid 351717514)
180. Sheth P, Delos Santos N, Seth A, LaRusso NF, and Rao RK. Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism. Am J Physiol Gastrointest 293: G308-G318, 2007. (Pubitemid 47105165)
181. Sheth P, Samak G, Shull JA, Seth A, and Rao R. Protein phosphatase 2A plays a role in hydrogen peroxide-induced disruption of tight junctions in Caco-2 cell monolayers. Biochem J 421: 59-70, 2009.
182. Shilatifard A, Lane WS, Jackson KW, Conaway RC, and Conaway JW. An RNA polymerase II elongation factor encoded by the human ELL gene. Science 271: 1873-1876, 1996. (Pubitemid 26112315)
183. Shumaker DK, Vann LR, Goldberg MW, Allen TD, and Wilson KL. TPEN, a Zn2 +/Fe2 + chelator with low affinity for Ca2 + , inhibits lamin assembly, destabilizes nuclear architecture and may independently protect nuclei from apoptosis in vitro. Cell Calcium 23: 151-164, 1998.
184. Singh U, Van Itallie CM, Mitic LL, Anderson JM, and McClane BA. CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin. J Biol Chem 275: 18407-18417, 2000. (Pubitemid 30414798)
185. Smales C, Ellis M, Baumber R, Hussain N, Desmond H, and Staddon JM. Occludin phosphorylation: identification of an occludin kinase in brain and cell extracts as CK2. FEBS Lett 545: 161-166, 2003. (Pubitemid 36694694)
186. Sorond FA and Ratan RR. Ironing-out mechanisms of neuronal injury under hypoxic-ischemic conditions and potential role of iron chelators as neuroprotective agents. Antioxid Redox Signal 2: 421-436, 2000.
187. Stamatovic SM, Keep RF, Wang MM, Jankovic I, and Andjelkovic AV. Caveolae-mediated internalization of occludin and Claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J Biol Chem 284: 19053-19066, 2009.
188. Steed E, Rodrigues NTL, Balda MS, and Matter K. Identification of marvelD3 as a tight junction-associated transmembrane protein of the occludin family. BMC Cell Biol 10: 371-379, 2009.
189. Stehbens WE. Oxidative stress in viral hepatitis and AIDS. Exp Mol Pathol 77: 121-132, 2004. (Pubitemid 39209294)
190. Sundstrom JM, Tash BR, Murakami T, Flanagan JM, Bewley MC, Stanley BA, Gonsar KB, and Antonetti DA. Identification and analysis of occludin phosphosites: a combined mass spectrometry and bioinformatics approach. J Proteome Res 8: 808-817, 2009.
191. Suzuki K, Kokai Y, Sawada N, Takakuwa R, Kuwahara K, Isogai E, Isogai H, and Mori M. SS1 Helicobacter pylori disrupts the paracellular barrier of the gastric mucosa and leads to neutrophilic gastritis in mice. Virchows Arch 440: 318-324, 2002. (Pubitemid 34230738)
192. Suzuki T, Elias BC, Seth A, Shen L, Turner JR, Giorgianni F, Desiderio D, Guntaka R, and Rao R. PKC eta regulates occludin phosphorylation and epithelial tight junction integrity. Proc Natl Acad Sci USA 106: 61-66, 2009.
193. Tavelin S, Hashimoto K, Malkinson J, Lazorova L, Toth I, and Artursson P. A new principle for tight junction modulation based on occludin peptides. Mol Pharmacol 64: 1530-1540, 2003. (Pubitemid 37532242)
194. Tobioka H, Isomura H, Kokai Y, Tokunaga Y, Yamaguchi J, and Sawada N. Occludin expression decreases with the progression of human endometrial carcinoma. Hum Pathol 35: 159-164, 2004. (Pubitemid 38240897)
195. Traweger A, Fang D, Liu YC, Stelzhammer W, Krizbai IA, Fresser F, Bauer HC, and Bauer H. The tight junctionspecific protein occludin is a functional target of the E3 ubiquitin-protein ligase itch. J Biol Chem277: 10201-10208, 2002. (Pubitemid 34968134)
196. Tsukita S and Furuse M. Occludin and claudins in tightjunction strands: leading or supporting players? Trends Cell Biol 9: 268-273, 1999. (Pubitemid 29305516)
197. Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, Mrsny RJ, Parkos CA, and Nusrat A. Mechanism of IFNgamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 16: 5040-5052, 2005. (Pubitemid 41416480)
198. Utepbergenov DI, Mertsch K, Sporbert A, Tenz K, Paul M, Haseloff RF, and Blasig IE. Nitric oxide protects bloodbrain barrier in vitro from hypoxia/reoxygenation-mediated injury. FEBS Lett 424: 197-201, 1998. (Pubitemid 28135313)
199. Van Itallie CM, Rogan S, Yu A, Vidal LS, Holmes J, and Anderson JM. Two splice variants of claudin-10 in the kidney create paracellular pores with different ion selectivities. Am J Physiol Renal 291: F1288-F1299, 2006. (Pubitemid 44887242)
200. Vietor I, Bader T, Paiha K, and Huber LA. Perturbation of the tight junction permeability barrier by occludin loop peptides activates beta-catenin/TCF/LEF-mediated transcription. EMBO Rep 2: 306-312, 2001. (Pubitemid 32401525)
201. Vincent T, Neve EPA, Johnson JR, Kukalev A, Rojo F, Albanell J, Pietras K, Virtanen I, Philipson L, Leopold PL, Crystal RG, de Herreros AG, Moustakas A, Pettersson RF, and Fuxe J. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 11: 943-950, 2009.
202. Wachtel M, Bolliger MF, Ishihara H, Frei K, Bluethmann H, and Gloor SM. Down-regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-kappa B activation. J Neurochem 78: 155-162, 2001. (Pubitemid 32622597)
203. Walter JK, Castro V, Voss M, Gast K, Rueckert C, Piontek J, and Blasig IE. Redox-sensitivity of the dimerization of occludin. Cell Mol Life Sci 66: 3655-3662, 2009.
204. Walter JK, Rueckert C, Voss M, Mueller SL, Piontek J, Gast K, and Blasig IE. The oligomerization of the coiled coildomain of occludin is redox sensitive. Ann N Y Acad Sci 1165: 19-27, 2009.
205. Wan H, Winton HL, Soeller C, Taylor GW, Gruenert DC, Thompson PJ, Cannell MB, Stewart GA, Garrod DR, and Robinson C. The transmembrane protein occludin of epithelial tight junctions is a functional target for serine peptidases from faecal pellets of Dermatophagoides pteronyssinus. Clin Exp Allergy 31: 279-294, 2001. (Pubitemid 32231861)
206. Wan H, Winton HL, Soeller C, Tovey ER, Gruenert DC, Thompson PJ, Stewart GA, Taylor GW, Garrod DR, Cannell MB, and Robinson C. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 104: 123-133, 1999. (Pubitemid 29534352)
207. Wang Q, Luo WJ, Zheng W, Liu YP, Xu H, Zheng G, Dai ZM, Zhang WB, Chen YM, and Chen JY. Iron supplement prevents lead-induced disruption of the blood-brain barrier during rat development. Toxicol Appl Pharmacol 219: 33-41, 2007. (Pubitemid 46237646)
208. Wang W, Dentler WL, and Borchardt RT. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol 280: H434-H440, 2001.
209. Wang ZL, Mandell KJ, Parkos CA, Mrsny RJ, and Nusrat A. The second loop of occludin is required for suppression of Raf1-induced tumor growth. Oncogene 24: 4412-4420, 2005. (Pubitemid 40961764)
210. Westphal JK, Dorfel MJ, Krug SM, Cording JD, Piontek J, Blasig IE, Tauber R, Fromm M, and Huber O. Tricellulin forms homomeric and heteromeric tight junctional complexes. Cell Mol Life Sci 67: 2057-2068, 2010.
211. Witt KA, Mark KS, Hom S, and Davis TP. Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Phys 285: H2820-H2831, 2003. (Pubitemid 37443103)
212. Wittchen ES, Haskins J, and Stevenson BR. Protein interactions at the tight junction: actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem 274: 35179-35185, 1999. (Pubitemid 129509574)
213. Wong CH, Mruk DD, Lee WM, and Cheng CY. Targeted and reversible disruption of the blood-testis barrier by an FSH mutant-occludin peptide conjugate. FASEB J 21: 438-448, 2007. (Pubitemid 46213491)
214. Wong CH, Mruk DD, Lui WY, and Cheng CY. Regulation of blood-testis barrier dynamics: an in vivo study. J Cell Sci 117: 783-798, 2004. (Pubitemid 38263222)
215. Wong V. Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am J Physiol Cell Physiol 273: C1859-C1867, 1997.
216. Wong V and Gumbiner BM. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 136: 399-409, 1997. (Pubitemid 27063089)
217. Wu ZY, Nybom P, and Magnusson KE. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell Microbiol 2: 11-17, 2000. (Pubitemid 30225063)
218. Yamamoto M, Ramirez SH, Sato S, Kiyota T, Cerny RL, Kaibuchi K, Persidsky Y, and Ikezu T. Phosphorylation of claudin-5 and occludin by Rho kinase in brain endothelial cells. Am J Pathol 172: 521-533, 2008. (Pubitemid 351282037)
219. Yamamoto T, Saeki Y, Kurasawa M, Kuroda S, Arase S, and Sasaki H. Effect of RNA interference of tight junctionrelated molecules on intercellular barrier function in cultured human keratinocytes. Arch Dermatol Res 300: 517-524, 2008.
220. Ye L, Martin TA, Parr C, Harrison GM, Mansel RE, and Jiang WG. Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. J Cell Physiol 196: 362-369, 2003. (Pubitemid 36775884)
221. Yu ASL, McCarthy KM, Francis SA, McCormack JM, Lai J, Rogers RA, Lynch RD, and Schneeberger EE. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol 288: C1231-C1241, 2005. (Pubitemid 40991060)
222. Zeissig S, Burgel N, Gunzel D, Richter J, Mankertz J, Wahnschaffe U, Kroesen AJ, Zeitz M, Fromm M, and Schulzke JD. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56: 61-72, 2007. (Pubitemid 46044890)
223. Zhang B, Abreu JG, Zhou K, Chen Y, Hu Y, Zhou T, He X, and Ma JX. Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family. Proc Natl Acad Sci USA 107: 6900-6905, 2010.
224. Zhang B, Hu Y, and Ma JX. Anti-inflammatory and antioxidant effects of SERPINA3K in the retina. Invest Ophthalmol Vis Sci 50: 3943-3952, 2009.
225. Zhang B and Ma JX. SERPINA3K prevents oxidative stress induced necrotic cell death by inhibiting calcium overload. PLoS One 3: e4077, 2008.
226. Zhong ZH, Deane R, Ali Z, Parisi M, Shapovalov Y, O'Banion MK, Stojanovic K, Sagare A, Boillee S, Cleveland DW, and Zlokovic BV. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 11: 420-422, 2008. (Pubitemid 351441888)